Literature DB >> 27616652

The association between muscle strengthening activities and atherogenic index of plasma.

Meghan K Edwards1, Paul D Loprinzi2.   

Abstract

Atherogenic index of plasma (AIP), calculated as LOG10(triglycerides/high-density lipoprotein-cholesterol), is considered to be a novel indicator of cardiovascular disease (CVD) risk. Muscle strengthening activities (MSA) have been shown to favorably associate with triglycerides and high-density lipoprotein cholesterol (HDL-C). The association between MSA and AIP has yet to be explored in a nationally representative sample of U.S. adults, which was the purpose of this brief report. Data from the 1999-2006 National Health and Nutrition Examination Survey were used (N=6694 adults 20-85yrs). AIP was obtained from a blood sample and a 2-item questionnaire was implemented to assess MSA participation over the previous 30-days. Individuals meeting MSA guidelines (vs. not) had reduced odds of having an elevated (>0.24) AIP (odds ratio=0.80; 95% confidence interval: 0.65-0.98; P=0.03). Muscle strengthening activities appear to be inversely associated with AIP. Engaging in MSA may be a strategy to mitigate risk for health outcomes associated with an elevated AIP, such as CVD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Lipoprotein; Physical activity; Triglycerides

Mesh:

Substances:

Year:  2016        PMID: 27616652     DOI: 10.1016/j.ypmed.2016.09.013

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  1 in total

1.  Cardiorespiratory Fitness, Physical Activity, Sedentary Time and Its Association with the Atherogenic Index of Plasma in Chilean Adults: Influence of the Waist Circumference to Height Ratio.

Authors:  Waleska Reyes-Ferrada; Patricio Solis-Urra; Julio Plaza-Díaz; Kabir P Sadarangani; Gerson Luis de Moraes Ferrari; Fernando Rodríguez-Rodríguez; Carlos Cristi-Montero
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.